Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes —
Background Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined. Methods We conducted searches of the published literature, the Web site of the Food ...